ZEAL:CPH
Zealand Pharma A/S
DKKÂ 268.00
arrow_downward
-1.72%(-4.70) 1D
Sep 28, 5:00:00 PM GMT+2 · DKK
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ZEAL...
Open
DKKÂ 272.90
High
DKKÂ 276.90
Low
DKKÂ 267.10
Mkt. cap
19.53B
Avg. vol.
397.64K
Volume
242.75K
52-wk high
DKKÂ 556.00
52-wk low
DKKÂ 233.50
Shares outstanding
71.61M
No. of employees
578
Open
DKKÂ 272.90
High
DKKÂ 276.90
Low
DKKÂ 267.10
Mkt. cap
19.53B
Avg. vol.
397.64K
Volume
242.75K
52-wk high
DKKÂ 556.00
52-wk low
DKKÂ 233.50
Shares outstanding
71.61M
No. of employees
578
News stories
From web sources and news partners
Yahoo Finance
·
4 hours ago
Zealand Pharma - Transactions related to share buy-back program (week 39, 2026)
Profile
Zealand Pharma A/S is a Danish biotechnology research company, which designs and develops peptide-based medicines, mainly focusing on metabolic diseases like diabetes and obesity. The company's head office is situated in Søborg near Copenhagen, and it has close to 200 employees. In 2018, they opened a subsidiary in the US. Zealand Pharma forms part of the Danish-Swedish life science cluster Medicon Valley. Wikipedia
About Zealand Pharma A/S
CEOAdam Steensberg
Employees578
FoundedApr 1, 1997
Headquarters-
SectorBiotechnology
Websitezealandpharma.com